Membership
The EORTC Breast Group is a multidisciplinary group and members of the group are
institutions.
Depending on the number of patients per year entered into the group’s trials,
institutions can be categorized into:
- active members: ≥ 15 patients/year;
- ordinary members: ≥ 5 patients/year and < 15 patients/year.
New members receive the status of probationary members for an observational period
of two years. During this period, at least 5 patients per year must be entered.
Institutions participating only in specific trials are foreign members.
Active members:
Active members are expected to contribute at least 15 evaluable patients per year. To
become an active member, an institution has to enter at least 15 patients for two
consecutive years and to pass the quality control review. When, for two consecutive
years, an active member contributes less than 15 evaluable patients per year, it will
become an ordinary member.
Active members should attend the twice-yearly meetings of the group regularly. They
are represented in the business meeting and have the right to vote for the election of
the officers of the group. They participate in the financial and strategic decisions of the
group.
Ordinary members:
Ordinary members have to contribute at least 5 evaluable patients per year. They
should attend the twice-yearly group meetings regularly. An ordinary member
contributing less than 5 evaluable patients for two consecutive years will be withdrawn
from the membership list. An institution whose membership has been withdrawn can
re-apply to the group after a waiting period of two years.
Probationary members:
Any institution active in the fields of clinical and experimental oncology, which agrees
to comply with the rules of the group, can apply for probationary membership. Details
of how to apply for membership can be found in Appendix I.
A new probationary member is elected by the group for two years. Based on the
accrual during these two years, the institution can become an active or an ordinary
member.
Foreign members:
These centers are allowed to participate only in pre-specified trials for which they have
received the status of “foreign members”.
This can either relate to:
- Centers belonging to another EORTC group and interested in participating in one
particular study of the Breast Group
or
- Centers from other groups (e.g. SAKK, NCIC, ECOG) participating in intergroup
studies initiated by the EORTC Breast Group
or
- Centers removed from the probationary members as described in the “Probationary
Members” section.
These centers will receive an invitation to the group meetings and a copy of all
information relating to the study in which they are participating.
Observers:
Observers are representatives from centers or from pharmaceutical companies, or
anybody who has expressed the wish to remain in contact with the EORTC Breast
Group. They will receive an invitation to the open group meetings, which they are
welcome to participate in.
NB : Patients recruited in IDBBC studies are taken into account for the membership
status of EORTC Breast Group.
For any further information regarding membership, please contact the EORTC Membership Committee at the following address: For more information about membership (How to join the EORTC Network) please go to |